| scholarly article | Q13442814 |
| P2093 | author name string | Daehee Hwang | |
| Wan-Uk Kim | |||
| Yune-Jung Park | |||
| Min Kyung Chung | |||
| P2860 | cites work | The synovial proteome: analysis of fibroblast-like synoviocytes | Q21195678 |
| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update | Q26859134 | ||
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| A generic protein purification method for protein complex characterization and proteome exploration | Q27861087 | ||
| Mass spectrometry-based proteomics | Q28182890 | ||
| Hydrogen exchange mass spectrometry for studying protein structure and dynamics | Q28301471 | ||
| Mass-spectrometry-based draft of the human proteome | Q29617249 | ||
| The next level of complexity: crosstalk of posttranslational modifications. | Q30356852 | ||
| Bioinformatics tools to identify and quantify proteins using mass spectrometry data | Q30777795 | ||
| Use of whole-blood transcriptomic profiling to highlight several pathophysiologic pathways associated with response to rituximab in patients with rheumatoid arthritis: data from a randomized, controlled, open-label trial | Q30807010 | ||
| A pattern of protein expression in peripheral blood mononuclear cells distinguishes rheumatoid arthritis patients from healthy individuals. | Q31036103 | ||
| Chronically inflamed synovium from spondyloarthropathy and rheumatoid arthritis investigated by protein expression profiling followed by tandem mass spectrometry | Q31162200 | ||
| Mass spectrometry for structural characterization of therapeutic antibodies | Q33362439 | ||
| Analyses of differential proteome of human synovial fibroblasts obtained from arthritis | Q33370957 | ||
| Polymorphisms of COTL1 gene identified by proteomic approach and their association with autoimmune disorders. | Q33420756 | ||
| Proteomics: quantitative and physical mapping of cellular proteins | Q33586063 | ||
| Implication of granulocyte-macrophage colony-stimulating factor induced neutrophil gelatinase-associated lipocalin in pathogenesis of rheumatoid arthritis revealed by proteome analysis | Q33596027 | ||
| 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative | Q34130671 | ||
| Mass spectrometry-based proteomics: existing capabilities and future directions | Q34267972 | ||
| Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis | Q34315745 | ||
| From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis | Q34472916 | ||
| Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide | Q34550160 | ||
| Treatment of rheumatoid arthritis with tumour necrosis factor inhibitors | Q34588629 | ||
| Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial | Q34651182 | ||
| Proteome and proteomics: new technologies, new concepts, and new words | Q34752561 | ||
| Proteomic analysis of synovial fibroblast-like synoviocytes from rheumatoid arthritis | Q34759806 | ||
| Bone erosions in rheumatoid arthritis can be repaired through reduction in disease activity with conventional disease-modifying antirheumatic drugs | Q34897514 | ||
| Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review. | Q35018275 | ||
| A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas | Q35264564 | ||
| Healing of erosions in rheumatoid arthritis | Q35549500 | ||
| Imaging: do erosions heal? | Q35553455 | ||
| EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). | Q35638360 | ||
| Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire | Q35740447 | ||
| A novel pathogenic role of the ER chaperone GRP78/BiP in rheumatoid arthritis | Q35894179 | ||
| Proteomic profiling following immunoaffinity capture of high-density lipoprotein: association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis | Q35899148 | ||
| A protein profile of visceral adipose tissues linked to early pathogenesis of type 2 diabetes mellitus | Q37623635 | ||
| Proteomics: a pragmatic perspective | Q37771859 | ||
| Analysis of post-translational modifications by LC-MS/MS. | Q37788631 | ||
| Mass spectrometry-based targeted quantitative proteomics: achieving sensitive and reproducible detection of proteins | Q38009277 | ||
| Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years | Q40213181 | ||
| Predicting mortality in patients with rheumatoid arthritis | Q40582797 | ||
| Patients with rheumatoid arthritis in clinical care | Q41828498 | ||
| Anti-citrullinated protein antibodies bind surface-expressed citrullinated Grp78 on monocyte/macrophages and stimulate tumor necrosis factor alpha production | Q43137492 | ||
| Study of the human plasma proteome of rheumatoid arthritis | Q43510264 | ||
| The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses | Q44240544 | ||
| Is GRP78/BiP a potential salivary biomarker in patients with rheumatoid arthritis? | Q51627228 | ||
| Urinary proteome profile predictive of disease activity in rheumatoid arthritis. | Q53260144 | ||
| Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis. | Q53523180 | ||
| Proteins related to the functions of fibroblast-like synoviocytes identified by proteomic analysis. | Q54324730 | ||
| 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative | Q56506042 | ||
| Proteomic Analysis of Peripheral Blood Mononuclear Cells: Selective Protein Processing Observed in Patients with Rheumatoid Arthritis | Q57369210 | ||
| Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis | Q61663306 | ||
| How to read radiographs according to the Sharp/van der Heijde method | Q73386051 | ||
| Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis | Q73573994 | ||
| Identification of radiologic healing phenomena in patients with rheumatoid arthritis | Q77411850 | ||
| The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. American Rheumatism Association | Q77701974 | ||
| Very recent onset arthritis--clinical, laboratory, and radiological findings during the first year of disease | Q78472006 | ||
| Protein biomarker analysis by mass spectrometry in patients with rheumatoid arthritis receiving anti-tumor necrosis factor-alpha antibody therapy | Q81483105 | ||
| Proteomics in rheumatology | Q82988851 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 177-85 | |
| P577 | publication date | 2015-08-01 | |
| P1433 | published in | Immune Network | Q26841916 |
| P1476 | title | Proteomics in Rheumatoid Arthritis Research | |
| P478 | volume | 15 |
| Q99635855 | Efficacy, safety and cost-effectiveness of a web-based platform delivering the results of a biomarker-based predictive model of biotherapy response for rheumatoid arthritis patients: a protocol for a randomized multicenter single-blind active contro |
| Q39062717 | Folate Receptor-Targeted Diagnostics and Therapeutics for Inflammatory Diseases |
| Q39298145 | Genomics, transcriptomics and proteomics to elucidate the pathogenesis of rheumatoid arthritis |
| Q41683397 | Identification of a 48 kDa form of unconventional myosin 1c in blood serum of patients with autoimmune diseases. |
| Q47400242 | Identification of novel systemic sclerosis biomarkers employing aptamer proteomic analysis |
| Q51572632 | Methotrexate affects HMGB1 expression in rheumatoid arthritis, and the downregulation of HMGB1 prevents rheumatoid arthritis progression. |
| Q64235920 | New Insights for RANKL as a Proinflammatory Modulator in Modeled Inflammatory Arthritis |
| Q37657244 | Urinary proteomics can define distinct diagnostic inflammatory arthritis subgroups |
Search more.